Pathologically-confirmed, resectable, squamous cell carcinoma of the oral cavity, oropharynx, larynx or hypopharynx
Item
patients must have pathologically-confirmed, resectable, squamous cell carcinoma of the oral cavity, oropharynx, larynx or hypopharynx
boolean
C0007137 (UMLS CUI [1,1])
C0679557 (UMLS CUI [1,2])
C0226896 (UMLS CUI [1,3])
C1514888 (UMLS CUI [1,4])
C0007137 (UMLS CUI [2,1])
C0679557 (UMLS CUI [2,2])
C1280659 (UMLS CUI [2,3])
C1514888 (UMLS CUI [2,4])
C0007137 (UMLS CUI [3,1])
C0679557 (UMLS CUI [3,2])
C0020629 (UMLS CUI [3,3])
C1514888 (UMLS CUI [3,4])
C0007137 (UMLS CUI [4,1])
C0679557 (UMLS CUI [4,2])
C0023078 (UMLS CUI [4,3])
C1514888 (UMLS CUI [4,4])
Diagnostic Neoplasm Staging
Item
disease must be stage i, ii, iii or iva
boolean
C0027646 (UMLS CUI [1])
Neoplasm surgically resectable | Curable with conventional surgery | Curable with radiation therapy
Item
tumor must be potentially surgically resectable and curable with conventional surgery and radiation therapy
boolean
C0027651 (UMLS CUI [1,1])
C1514888 (UMLS CUI [1,2])
C0027651 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
C1276305 (UMLS CUI [2,3])
C0332149 (UMLS CUI [2,4])
C0027651 (UMLS CUI [3,1])
C0543467 (UMLS CUI [3,2])
C1276305 (UMLS CUI [3,3])
C0332149 (UMLS CUI [3,4])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Informed consent
Item
patients must give documented informed consent to participate in this study
boolean
C0021430 (UMLS CUI [1])
Evidence of distant metastases
Item
documented evidence of distant metastases
boolean
C0027627 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
Acute serious commorbidity that would preclude surgical resection
Item
ongoing acute medical condition such as uncontrolled coronary artery disease, emphysema, or diabetes mellitus that would preclude surgical resection
boolean
C0009488 (UMLS CUI [1,1])
C0205178 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0543467 (UMLS CUI [1,4])
C1299582 (UMLS CUI [1,5])
Patients of childbearing potential must be willing to use Hormonal contraceptives or Barriere method of contraception
Item
pregnancy or lactation; patients of child bearing age must agree to use adequate contraception (hormonal or barrier method of birth control) prior to study entry and for the duration of soy administration
boolean
C3831118 (UMLS CUI [1,1])
C0009905 (UMLS CUI [1,2])
C0600109 (UMLS CUI [1,3])
C3831118 (UMLS CUI [2,1])
C0004764 (UMLS CUI [2,2])
C0600109 (UMLS CUI [2,3])
Comorbidity which could interfere with patient's protocol compliance
Item
a medical or psychiatric illness which would compromise the patient's ability to tolerate this treatment or comply with administration of study drug
boolean
C0009488 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
Prisoners
Item
patients residing in prison
boolean
C0033167 (UMLS CUI [1])
Medical history of breast cancer | Medical history of ovarian cancer
Item
any patient with a history of breast or ovarian cancer
boolean
C0678222 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C0029925 (UMLS CUI [2,1])
C0262926 (UMLS CUI [2,2])
Hypersensitivity to soy products
Item
allergy to soy products
boolean
C0020517 (UMLS CUI [1,1])
C1532456 (UMLS CUI [1,2])